JBIO
Jade Biosciences, Inc.
+0.51 (+3.06%)17.16USD318K成交股數1.1B市值2.0本益比(近四季)–股價營收比–營收年增(近四季)2026-11-12下次財報
內部人交易 SEC Form 4 · 董事、高階主管與持股 10% 以上股東 · 交易後兩個營業日內申報
買賣點與股價近一年
● 公開市場買進 · ● 公開市場賣出 · 空心 = 10b5-1 預設計畫(事先排程,不代表當下看法)。近一年,只畫 P / S 兩種代碼。
統計
| 近 90 天 買進筆數 · 金額 · 人數 | 0 · 0.00 · 0 |
|---|---|
| 近 90 天 賣出筆數 · 金額 · 人數 | 0 · 0.00 · 0 |
| 其中 10b5-1 計畫賣出 | 0 筆 |
| 近 180 天 買進 · 賣出金額 | 0.00 · 0.00 |
| 近 180 天 淨額 | 0.00 |
公開市場買進(P)是內部人自掏腰包,通常比賣出更有資訊含量 —— 賣出的理由很多(繳稅、分散、買房),買進的理由只有一個。
10b5-1 是事先排定的交易計畫,執行時點不反映當下看法。獲配股票(A)、繳稅扣股(F)、選擇權執行(M)是薪酬流程,不是意見。
| 交易日 | 申報日 | 申報人 | 職稱 | 代碼 | 股數 | 價格 | 金額 | 交易後持股 | 原件 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-12 | 02-13 | Balta Elizabeth | See Remarks | A 獲配股票 | 28.1K | – | – | 28.1K | SEC |
| 2026-02-12 | 02-13 | Frohlich Tom | Chief Executive Officer | A 獲配股票 | 78.8K | – | – | 86.3K | SEC |
| 2026-02-12 | 02-13 | Dahms Bradford D. | Chief Financial Officer | A 獲配股票 | 37.8K | – | – | 37.8K | SEC |
| 2026-02-12 | 02-13 | King Andrew James | See Remarks | A 獲配股票 | 41.3K | – | – | 386K | SEC |
| 2025-10-06 | 10-08 | Kiselak Tomas | Director,TenPercentOwner | A 獲配股票 | 1.3M | 9.14 | 12.2M | 1.9M | SEC |
| 2025-10-06 | 10-08 | Fairmount Healthcare Fund II L.P. | Director,TenPercentOwner | A 獲配股票 | 1.3M | 9.14 | 12.2M | 1.9M | SEC |
| 2025-10-06 | 10-08 | Harwin Peter Evan | Director,TenPercentOwner | A 獲配股票 | 1.3M | 9.14 | 12.2M | 1.9M | SEC |
| 2025-10-06 | 10-08 | Fairmount Healthcare Co-Invest IV L.P. | Director,TenPercentOwner | A 獲配股票 | 1.3M | 9.14 | 12.2M | 1.9M | SEC |
| 2025-10-06 | 10-08 | Fairmount Funds Management LLC | Director,TenPercentOwner | A 獲配股票 | 1.3M | 9.14 | 12.2M | 1.9M | SEC |
| 2025-05-16 | 05-19 | Frohlich Tom | Chief Executive Officer | P 公開市場買進 | 6.0K | 7.40 | 44K | 6.0K | SEC |
| 2025-04-28 | 04-30 | RA CAPITAL MANAGEMENT, L.P. | TenPercentOwner | J 其他 | 1.1M | – | – | 1.3M | SEC |
| 2025-04-28 | 04-30 | Kolchinsky Peter | TenPercentOwner | J 其他 | 1.1M | – | – | 1.3M | SEC |
| 2025-04-28 | 04-30 | RA Capital Healthcare Fund LP | TenPercentOwner | J 其他 | 1.1M | – | – | 1.3M | SEC |
| 2025-04-28 | 04-30 | Shah Rajeev M. | TenPercentOwner | J 其他 | 1.1M | – | – | 1.3M | SEC |
| 2024-08-01 | 08-02 | Dake Benjamin T | SEE REMARKS | M 選擇權執行 | 1.5K | 1.74 | 3K | 14.3K | SEC |
| 2024-07-31 | 08-02 | Dake Benjamin T | SEE REMARKS | M 選擇權執行 | 11.5K | 1.74 | 20K | 12.7K | SEC |
| 2024-06-17 | 06-20 | RA CAPITAL MANAGEMENT, L.P. | Director,TenPercentOwner | P 公開市場買進 | 928K | 1.67 | 1.5M | 7.9M | SEC |
| 2024-06-17 | 06-20 | Shah Rajeev M. | Director,TenPercentOwner | P 公開市場買進 | 928K | 1.67 | 1.5M | 7.9M | SEC |
| 2024-06-17 | 06-20 | RA Capital Nexus Fund, L.P. | Director | P 公開市場買進 | 928K | 1.67 | 1.5M | 7.9M | SEC |
| 2024-06-17 | 06-20 | RA Capital Healthcare Fund LP | Director,TenPercentOwner | P 公開市場買進 | 928K | 1.67 | 1.5M | 7.9M | SEC |
| 2024-06-17 | 06-20 | Kolchinsky Peter | Director,TenPercentOwner | P 公開市場買進 | 928K | 1.67 | 1.5M | 7.9M | SEC |
| 2024-06-14 | 06-14 | Verwijs Marinus | CHIEF TECHNICAL OFFICER | M 選擇權執行 | 10.6K | 14.59 | 155K | 10.6K | SEC |
| 2024-06-14 | 06-14 | Eldridge George A | SEE REMARKS | M 選擇權執行 | 15.0K | 2.14 | 32K | 20.0K | SEC |
| 2024-06-14 | 06-14 | Verwijs Marinus | CHIEF TECHNICAL OFFICER | S 公開市場賣出(10b5-1) | 10.6K | 25.00 | 265K | 0 | SEC |
| 2024-06-14 | 06-14 | Eldridge George A | SEE REMARKS | S 公開市場賣出(10b5-1) | 15.0K | 25.03 | 375K | 5.0K | SEC |
| 2024-06-13 | 06-14 | Gillies Hunter | CHIEF MEDICAL OFFICER | M 選擇權執行 | 6.0K | 2.14 | 13K | 11.6K | SEC |
| 2024-06-13 | 06-14 | Gillies Hunter | CHIEF MEDICAL OFFICER | S 公開市場賣出(10b5-1) | 6.0K | 24.50 | 147K | 5.6K | SEC |
| 2024-05-17 | 05-17 | Gillies Hunter | CHIEF MEDICAL OFFICER | M 選擇權執行 | 4.0K | 2.14 | 9K | 9.6K | SEC |
| 2024-05-17 | 05-17 | Gillies Hunter | CHIEF MEDICAL OFFICER | S 公開市場賣出(10b5-1) | 86 | 21.86 | 2K | 5.6K | SEC |
| 2024-05-17 | 05-17 | Gillies Hunter | CHIEF MEDICAL OFFICER | S 公開市場賣出(10b5-1) | 3.9K | 21.07 | 82K | 5.7K | SEC |
| 2024-05-16 | 05-17 | NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | S 公開市場賣出(10b5-1) | 1.3K | 21.92 | 28K | 0 | SEC |
| 2024-05-16 | 05-17 | NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | S 公開市場賣出(10b5-1) | 8.7K | 21.52 | 187K | 1.3K | SEC |
| 2024-05-16 | 05-17 | NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | M 選擇權執行 | 10.0K | 2.14 | 21K | 10.0K | SEC |
| 2024-05-02 | 05-03 | Verwijs Marinus | CHIEF TECHNICAL OFFICER | S 公開市場賣出 | 2.0K | 21.02 | 42K | 0 | SEC |
| 2024-05-01 | 05-03 | NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | M 選擇權執行 | 10.0K | 2.14 | 21K | 10.0K | SEC |
| 2024-05-01 | 05-03 | NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | S 公開市場賣出(10b5-1) | 1.4K | 19.91 | 27K | 0 | SEC |
| 2024-05-01 | 05-03 | NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | S 公開市場賣出(10b5-1) | 965 | 20.87 | 20K | 0 | SEC |
| 2024-05-01 | 05-03 | NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | S 公開市場賣出(10b5-1) | 9.0K | 20.34 | 184K | 965 | SEC |
| 2024-04-17 | 04-19 | Dake Benjamin T | SEE REMARKS | S 公開市場賣出(10b5-1) | 338 | 23.17 | 8K | 1.4K | SEC |
| 2024-04-17 | 04-19 | Gillies Hunter | CHIEF MEDICAL OFFICER | S 公開市場賣出(10b5-1) | 311 | 23.33 | 7K | 3.3K | SEC |
| 2024-04-17 | 04-19 | Dake Benjamin T | SEE REMARKS | S 公開市場賣出(10b5-1) | 68 | 23.97 | 2K | 1.3K | SEC |
| 2024-04-17 | 04-19 | Gillies Hunter | CHIEF MEDICAL OFFICER | S 公開市場賣出(10b5-1) | 3.7K | 22.30 | 82K | 3.6K | SEC |
| 2024-04-17 | 04-19 | Dake Benjamin T | SEE REMARKS | S 公開市場賣出(10b5-1) | 6.4K | 22.32 | 144K | 1.7K | SEC |
| 2024-04-17 | 04-19 | Dake Benjamin T | SEE REMARKS | M 選擇權執行 | 6.9K | 2.14 | 15K | 8.1K | SEC |
| 2024-04-17 | 04-19 | Gillies Hunter | CHIEF MEDICAL OFFICER | M 選擇權執行 | 4.0K | 1.74 | 7K | 7.3K | SEC |
| 2024-04-16 | 04-18 | NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | S 公開市場賣出(10b5-1) | 5.5K | 24.94 | 137K | 0 | SEC |
| 2024-04-16 | 04-18 | NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | M 選擇權執行 | 10.0K | 2.14 | 21K | 10.0K | SEC |
| 2024-04-16 | 04-18 | NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | S 公開市場賣出(10b5-1) | 4.5K | 24.40 | 110K | 5.5K | SEC |
| 2024-04-10 | 04-12 | Eldridge George A | SEE REMARKS | S 公開市場賣出(10b5-1) | 6.7K | 26.77 | 180K | 2.7K | SEC |
| 2024-04-10 | 04-12 | Eldridge George A | SEE REMARKS | M 選擇權執行 | 7.5K | 2.14 | 16K | 9.5K | SEC |
| 2024-04-10 | 04-12 | Eldridge George A | SEE REMARKS | S 公開市場賣出(10b5-1) | 771 | 27.56 | 21K | 2.0K | SEC |
| 2024-04-09 | 04-11 | GRAYZEL DAVID S. | Director | S 公開市場賣出 | 11.9K | 28.15 | 334K | 14.5K | SEC |
| 2024-04-01 | 04-03 | Verwijs Marinus | CHIEF TECHNICAL OFFICER | M 選擇權執行 | 5.3K | 14.59 | 77K | 5.3K | SEC |
| 2024-04-01 | 04-03 | NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | S 公開市場賣出(10b5-1) | 1.0K | 31.95 | 32K | 0 | SEC |
| 2024-04-01 | 04-03 | NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | S 公開市場賣出(10b5-1) | 2.9K | 31.02 | 88K | 1.0K | SEC |
| 2024-04-01 | 04-03 | NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | S 公開市場賣出(10b5-1) | 1.6K | 29.90 | 49K | 3.9K | SEC |
| 2024-04-01 | 04-03 | NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | S 公開市場賣出(10b5-1) | 4.5K | 28.96 | 130K | 5.5K | SEC |
| 2024-04-01 | 04-03 | NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | M 選擇權執行 | 10.0K | 2.14 | 21K | 10.0K | SEC |
| 2024-04-01 | 04-03 | Dake Benjamin T | SEE REMARKS | S 公開市場賣出(10b5-1) | 3.3K | 31.97 | 106K | 1.3K | SEC |
| 2024-04-01 | 04-03 | Dake Benjamin T | SEE REMARKS | M 選擇權執行 | 3.3K | 10.61 | 35K | 4.6K | SEC |
| 2024-04-01 | 04-03 | Eldridge George A | SEE REMARKS | S 公開市場賣出(10b5-1) | 12.5K | 31.23 | 390K | 2.0K | SEC |
| 2024-04-01 | 04-03 | Verwijs Marinus | CHIEF TECHNICAL OFFICER | S 公開市場賣出(10b5-1) | 3.8K | 28.87 | 110K | 1.5K | SEC |
| 2024-04-01 | 04-03 | Eldridge George A | SEE REMARKS | M 選擇權執行 | 12.5K | 2.14 | 27K | 14.5K | SEC |
| 2024-04-01 | 04-03 | Verwijs Marinus | CHIEF TECHNICAL OFFICER | S 公開市場賣出(10b5-1) | 1.5K | 30.00 | 45K | 0 | SEC |
| 2024-03-28 | 04-01 | Gillies Hunter | CHIEF MEDICAL OFFICER | M 選擇權執行 | 9.0K | 2.14 | 19K | 12.3K | SEC |
| 2024-03-28 | 04-01 | Gillies Hunter | CHIEF MEDICAL OFFICER | S 公開市場賣出(10b5-1) | 9.0K | 29.50 | 266K | 3.3K | SEC |
| 2024-03-27 | 03-28 | Dake Benjamin T | SEE REMARKS | S 公開市場賣出(10b5-1) | 11.1K | 27.97 | 310K | 1.3K | SEC |
| 2024-03-27 | 03-28 | Dake Benjamin T | SEE REMARKS | M 選擇權執行 | 11.1K | 10.61 | 117K | 12.4K | SEC |
| 2024-03-25 | 03-27 | Dake Benjamin T | SEE REMARKS | S 公開市場賣出(10b5-1) | 3.4K | 28.01 | 96K | 1.3K | SEC |
| 2024-03-25 | 03-27 | Dake Benjamin T | SEE REMARKS | M 選擇權執行 | 3.4K | 10.61 | 36K | 4.7K | SEC |
| 2024-03-19 | 03-20 | Verwijs Marinus | CHIEF TECHNICAL OFFICER | S 公開市場賣出(10b5-1) | 2.5K | 25.68 | 65K | 2.8K | SEC |
| 2024-03-19 | 03-20 | Verwijs Marinus | CHIEF TECHNICAL OFFICER | M 選擇權執行 | 5.3K | 14.59 | 77K | 5.3K | SEC |
| 2024-03-19 | 03-20 | Verwijs Marinus | CHIEF TECHNICAL OFFICER | S 公開市場賣出(10b5-1) | 2.8K | 26.46 | 73K | 0 | SEC |
| 2024-03-18 | 03-20 | Gillies Hunter | CHIEF MEDICAL OFFICER | S 公開市場賣出(10b5-1) | 613 | 26.40 | 16K | 3.3K | SEC |
| 2024-03-18 | 03-20 | Gillies Hunter | CHIEF MEDICAL OFFICER | S 公開市場賣出(10b5-1) | 6.4K | 25.81 | 165K | 3.9K | SEC |
| 2024-03-18 | 03-20 | Gillies Hunter | CHIEF MEDICAL OFFICER | M 選擇權執行 | 3.0K | 2.14 | 6K | 10.3K | SEC |
| 2024-03-18 | 03-20 | Gillies Hunter | CHIEF MEDICAL OFFICER | M 選擇權執行 | 4.0K | 1.74 | 7K | 7.3K | SEC |
| 2024-03-18 | 03-20 | Dake Benjamin T | SEE REMARKS | S 公開市場賣出(10b5-1) | 7.6K | 26.48 | 201K | 1.3K | SEC |
| 2024-03-18 | 03-20 | Dake Benjamin T | SEE REMARKS | S 公開市場賣出(10b5-1) | 27.5K | 25.74 | 707K | 8.9K | SEC |
| 2024-03-18 | 03-20 | Dake Benjamin T | SEE REMARKS | M 選擇權執行 | 14.5K | 10.61 | 154K | 36.3K | SEC |
機構持股(13F) 管理規模 1 億美元以上的機構,每季末後 45 天內申報 · 最新 2026-06-30
前 25 大持有機構季末市值 · 與前一季股數比較
| 機構 | 持股 | 季末市值 | 股數季變化 | 動作 |
|---|---|---|---|---|
| FMR LLC | 9.1M | 203M | 新進 | 新進 |
| Jupiter Topco LLC | 6.3M | 139M | 新進 | 新進 |
| Fairmount Funds Management LLC | 4.6M | 101M | 新進 | 新進 |
| RA CAPITAL MANAGEMENT, L.P. | 3.7M | 81.6M | 新進 | 新進 |
| Venrock Adviser, LLC | 3.2M | 71.6M | 新進 | 新進 |
| Bellevue Group AG | 3.1M | 67.9M | 新進 | 新進 |
| Paradigm Biocapital Advisors LP | 2.9M | 63.5M | 新進 | 新進 |
| BlackRock, Inc. | 2.8M | 62.2M | 新進 | 新進 |
| FRANKLIN RESOURCES INC | 2.8M | 62.0M | 新進 | 新進 |
| STATE STREET CORP | 2.3M | 51.9M | 新進 | 新進 |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.2M | 49.9M | 新進 | 新進 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1.9M | 42.5M | 新進 | 新進 |
| Polar Capital Holdings Plc | 1.8M | 41.0M | 新進 | 新進 |
| Avidity Partners Management LP | 1.7M | 37.8M | 新進 | 新進 |
| Remedium Capital Partners, LLC | 1.6M | 35.1M | 新進 | 新進 |
| Soleus Capital Management, L.P. | 1.6M | 34.5M | 新進 | 新進 |
| JPMORGAN CHASE & CO | 1.5M | 32.6M | 新進 | 新進 |
| BAKER BROS. ADVISORS LP | 1.2M | 27.3M | 新進 | 新進 |
| Logos Global Management LP | 1.1M | 25.0M | 新進 | 新進 |
| Versant Venture Management, LLC | 992K | 22.0M | 新進 | 新進 |
| ACORN CAPITAL ADVISORS, LLC | 987K | 21.9M | 新進 | 新進 |
| GEODE CAPITAL MANAGEMENT, LLC | 985K | 21.9M | 新進 | 新進 |
| 城堡 CITADEL ADVISORS LLC | 929K | 20.7M | 新進 | 新進 |
| Foresite Capital Management VI LLC | 887K | 19.7M | 新進 | 新進 |
| Balyasny Asset Management L.P. | 879K | 19.5M | 新進 | 新進 |
持有機構數近 12 季
每季 13F 申報中持有本股的機構家數;綠柱 = 比上季少。機構數是「有多少人在船上」,不是「買了多少」。
| 持有機構 · 季變化 | 155 +35 |
|---|---|
| 新進 / 出清 / 加碼 / 減碼 | 155 / 0 / 0 / 0 |
| 機構合計持股 · 佔流通股 | 72.9M · 100.0% |
| 合計季末市值 | 1.6B |
13F 只申報多頭部位(含可轉債與選擇權,選擇權這裡已排除),不申報放空,也不申報 1 億美元以下的機構。同一集團多個申報主體會各算一家。
放空餘額 FINRA 每月兩次(15 日與月底結算)· 最新 2026-08-31
空單佔流通股近 13 個月
FINRA 每月兩次結算的空單餘額佔流通股數的比例,近 13 個月。滑到柱子看股數與回補天數。
最新一期
| 空單股數 | 10.0M |
|---|---|
| 與上期比 | +3.6% |
| 佔流通股數 | 15.72% |
| 日均成交量 | 607K |
| 回補天數 | 16.5 天 |
空單佔比 10% 以上算高、20% 以上算很高(這是通行的說法,不是本站的判斷)。回補天數 = 空單 ÷ 日均量,天數愈長,空方要出場時愈容易推升股價。
放空餘額是「有人借股票賣掉還沒還」的存量,不代表看空的人正在加碼;避險基金做多空配對時也會產生空單。
| 結算日 | 空單股數 | 與上期比 | 佔流通股 | 日均量 | 回補天數 |
|---|---|---|---|---|---|
| 2026-08-31 | 10.0M | +3.6% | 15.72% | 607K | 16.5 |
| 2026-08-14 | 9.7M | +11.0% | 15.17% | 951K | 10.2 |
| 2026-07-31 | 8.7M | +15.4% | 13.67% | 756K | 11.5 |
| 2026-07-15 | 7.5M | -7.6% | 11.84% | 1.1M | 7.2 |
| 2026-06-30 | 8.1M | +64.7% | 12.81% | 1.7M | 4.9 |
| 2026-06-15 | 4.9M | +56.4% | 7.78% | 1.6M | 3.1 |
| 2026-05-29 | 3.2M | -6.9% | 4.97% | 583K | 5.4 |
| 2026-05-15 | 3.4M | +9.7% | 5.34% | 444K | 7.7 |
| 2026-04-30 | 3.1M | +1.2% | 4.87% | 781K | 4.0 |
| 2026-04-15 | 3.1M | +144.6% | 4.81% | 810K | 3.8 |
| 2026-03-31 | 1.3M | -18.4% | 1.97% | 553K | 2.3 |
| 2026-03-13 | 1.5M | -1.7% | 2.41% | 349K | 4.4 |
| 2026-02-27 | 1.6M | +0.2% | 2.46% | 214K | 7.3 |
| 2026-02-13 | 1.6M | +7.7% | 2.45% | 227K | 6.9 |
| 2026-01-30 | 1.4M | +7.5% | 2.28% | 256K | 5.7 |
| 2026-01-15 | 1.3M | -13.0% | 2.12% | 314K | 4.3 |
| 2025-12-31 | 1.5M | +47.9% | 2.43% | 465K | 3.3 |
| 2025-12-15 | 1.0M | -10.2% | 1.64% | 320K | 3.3 |
| 2025-11-28 | 1.2M | +8.9% | 1.83% | 226K | 5.2 |
| 2025-11-14 | 1.1M | +3.9% | 1.68% | 221K | 4.8 |
| 2025-10-31 | 1.0M | -39.6% | 1.62% | 190K | 5.4 |
| 2025-10-15 | 1.7M | -2.9% | 2.68% | 212K | 8.1 |
| 2025-09-30 | 1.8M | +0.7% | 2.76% | 71.4K | 24.6 |
| 2025-09-15 | 1.7M | -3.5% | 2.74% | 56.6K | 30.8 |
| 2025-08-29 | 1.8M | -4.9% | 2.84% | 107K | 16.8 |
| 2025-08-15 | 1.9M | +4.5% | 2.99% | 103K | 18.4 |